Early results were announced today for clinical trials involving 43,538 volunteers that showed a robust 90% success rate for protecting people against coronavirus.  As part of the Phase–3 trials launched in July by developers Pfizer and BioNTech, the participants from diverse backgrounds in six countries—in the US, Germany, Brazil, Argentina, South Africa, and Turkey—received two […]

The post ‘Watershed’ Coronavirus Vaccine Looks to Be 90% Effective in Phase 3 Trial of 43,500 People, Reports Pfizer appeared first on Good News Network.

Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.